Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias

Promising results have been reported for adult patients with high-risk hematologic malignancies undergoing haploidentical bone marrow transplant (haploBMT) with posttransplant cyclophosphamide (PTCy). To our knowledge, we report results from the first multicenter trial for pediatric and young adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Fierro-Pineda, Juan C., Tsai, Hua-Ling, Blackford, Amanda, Cluster, Andrew, Caywood, Emi, Dalal, Jignesh, Davis, Jeffrey, Egeler, Maarten, Huo, Jeffrey, Hudspeth, Michelle, Keating, Amy, Kelly, Susan S., Krueger, Joerg, Lee, Dean, Lehmann, Leslie, Madden, Lisa, Oshrine, Benjamin, Pulsipher, Michael A., Fry, Terry, Symons, Heather J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546347/
https://www.ncbi.nlm.nih.gov/pubmed/37257193
http://dx.doi.org/10.1182/bloodadvances.2023010281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546347/
https://www.ncbi.nlm.nih.gov/pubmed/37257193
http://dx.doi.org/10.1182/bloodadvances.2023010281

Ejemplares similares